Yolanda Bryce
Papers
1
Total Citations
2
H-Index
1
About
Dr. Yolanda Bryce is a pioneering oncologist whose research bridges immunotherapy, cryoablation, and breast cancer treatment, with a particular focus on triple-negative breast cancer (TNBC)—one of the most aggressive subtypes. Her landmark work, a randomized phase II study published in 2019, investigates the peri-operative combination of ipilimumab, nivolumab, and cryoablation versus standard care in women with residual, early-stage, resectable TNBC after neoadjuvant chemotherapy. This study, which has garnered 2 citations, represents a novel approach to harnessing the immune system through localized tumor destruction, aiming to improve outcomes in a patient population with high recurrence risk. Dr. Bryce’s contributions are notable for integrating interventional oncology techniques with cutting-edge immunotherapy, potentially transforming treatment paradigms for hard-to-treat cancers. Her work underscores a commitment to personalized, multimodal strategies that address unmet needs in breast cancer care. For students and researchers, Dr. Bryce exemplifies how cross-disciplinary innovation can drive progress in oncology, offering hope for more effective, less toxic therapies.
Research Focus
Key Achievements
Top Papers
- 1